Bota Bio Co., Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular (NCT04141241) | Bota Bio Co., Ltd. | 2016-03-04 |
Track Bota Bio Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.